Modifications by SRI enhance function and durability of affordable purification material.
An SRI-led team is improving a new two-step process for the production of transportation fuels from microalgae.
In a nuclear or radiological incident, first responders must quickly measure the radiation exposure of a large number of individuals, since treatment options are radiation dose-dependent and time-sensitive. SRI is developing a biodosimeter to meet this critical challenge.
SRI is identifying candidates for advanced therapies in multiple disease areas by developing compounds from synthetically optimized, natural dietary products.
SRI's process produces pure hydrogen while capturing carbon dioxide and acid gases.
SRI has developed a green, cost-effective approach to create liquid fuels from existing natural resources.
SRI is developing a safe, low-pressure, conformable natural gas tank for light-duty vehicles.
Novel molecular targets of several cytokines are being evaluated by SRI scientists, with the goal of designing a small-molecule drug to block responses involved in many of these inflammatory diseases.
SRI is developing a novel point-of-care tool for the early detection of devastating diseases.
SRI’s carbon capture system can make economic sense today at facilities that produce and consume carbon dioxide.
Together with GexCon US, SRI is designing and conducting experiments to improve and validate tools used to minimize the risk of explosions or fires on offshore platforms.
SRI has developed a breakthrough technology for diagnosing and predicting fatigue failure in pipelines, aircraft, bridges, power plants, and other structures using quantitative 3D fractography.
SRI is seeking new treatments for tuberculosis, a global health crisis.
SRI is developing small, highly sensitive arrays for pervasive monitoring of chemical and biological processes in the ocean and other environments.
SRI’s hollow fiber membrane separates hydrogen from carbon dioxide at high temperatures and improves the economics of carbon capture from IGCC plants.
SRI has partnered with Sandia National Laboratories to provide the data necessary to ensure that hydrogen can be used safely as a transportation fuel.
SRI’s mixed salt process uses known solvents in a new way to dramatically improve the economics of carbon capture.
SRI has patented a novel approach to vaccine delivery that is safe for pediatric use, eliminating the need for painful injections.
SRI is developing technologies that could significantly improve tomographic medical imaging for cancer treatment and research.
SRI has developed a novel approach to safely and efficiently render harmless weapons and ammunition that are no longer needed for military use.
To meet an important military challenge, SRI is designing a sensor system that can disappear on command.
Through a broad range of services for the National Institutes of Health, SRI is accelerating preclinical development of potential therapies for diseases that affect millions of people.
SRI is co-developing a system for cooling water discharge ponds at thermoelectric power plants.
SRI sleep researchers are working to discover and develop new treatments for narcoleptic patients.
SRI is developing a new film to reduce heat loss through single-pane windows.